Related Experiment Video
Updated: Jan 24, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Oropharyngeal Colostrum for Preterm Infants: A Systematic Review and Meta-Analysis
Harshad Panchal1,2,3, Gayatri Athalye-Jape1,2,3, Sanjay Patole1,3
1Neonatal Directorate, King Edward Memorial Hospital for Women, Perth, Western Australia.
Insights
Oropharyngeal colostrum (OPC) administration is safe for preterm infants but did not significantly improve key health outcomes like necrotizing enterocolitis or sepsis in this review. Further research is needed to confirm potential benefits.
Area of Science:
- Neonatal Medicine
- Pediatric Gastroenterology
- Immunology
Background:
- Oropharyngeal colostrum (OPC) administration is a potential intervention for preterm infants.
- Previous studies suggest OPC may be safe, feasible, and beneficial for this vulnerable population.
- The immunomodulatory and nutritional effects of OPC warrant further investigation.
Purpose of the Study:
- To systematically review and assess the effects of oropharyngeal colostrum (OPC) administration in preterm infants.
- To evaluate the impact of OPC on major neonatal outcomes including necrotizing enterocolitis, sepsis, and mortality.
- To synthesize evidence from randomized controlled trials (RCTs) and non-RCTs regarding OPC's efficacy and safety.
Main Methods:
- A systematic review and meta-analysis of randomized controlled trials (RCTs) and non-randomized controlled trials (non-RCTs).
- Comprehensive literature search across multiple databases (MEDLINE, EMBASE, Cochrane) and gray literature up to April 2018.
- Inclusion of 6 RCTs (n=269) and 4 non-RCTs (n=737); one RCT on bovine colostrum was excluded.
Main Results:
- Meta-analysis of RCT data revealed no significant differences in the incidence of stage 2 necrotizing enterocolitis, late-onset sepsis, or all-cause mortality.
- OPC administration did not significantly alter the duration of hospital stay or time to full enteral feeds in preterm infants.
- OPC increased secretory IgA and lactoferrin concentrations and had a transient effect on the oral microbiome; no adverse events were reported.
Conclusions:
- Current evidence suggests oropharyngeal colostrum (OPC) is safe and feasible for preterm infants but does not demonstrate significant benefits for major clinical outcomes.
- The overall quality of evidence is very low, highlighting limitations in existing studies.
- Larger, adequately powered RCTs are essential to definitively establish the potential nutritional and immunomodulatory benefits of OPC in preterm neonates.
Abstract:
Administration of oropharyngeal colostrum (OPC) is safe, feasible, and potentially beneficial in preterm infants. We aimed to assess the effects of OPC in preterm infants. A systematic review of randomized controlled trials (RCTs) and non-RCTs of OPC administration in preterm infants was conducted. We searched MEDLINE via PubMed and Ovid, EMBASE, the Cochrane Central Register of Controlled Trials, Emcare databases, abstracts of Pediatric Academic Societies meetings, and gray literature in April 2018. Six RCTs (n = 269) and 4 non-RCTs (n = 737) were included. One RCT (n = 40) focused on enteral bovine colostrum and hence was excluded from our review. Five of the 6 RCTs had unclear risk of bias in many domains of assessment. Meta-analysis (random effects model) of RCT data showed no significant difference in ≥stage 2 necrotizing enterocolitis (RR: 0.83; 95% CI: 0.39, 1.75; P = 0.62), late-onset sepsis (RR: 0.78; 95% CI: 0.50, 1.22; P = 0.28), all-cause mortality (RR: 0.74; 95% CI: 0.27, 2.06; P = 0.56); duration of hospital stay (mean difference [MD]: -1.65 d; 95% CI: -10.09, 6.80; P = 0.70), and time to full feeds (MD: -2.86 d; 95% CI: -6.49, 0.77; P = 0.12). Meta-analysis of data from non-RCTs also showed no benefit for any of these outcomes. OPC increased secretory IgA and lactoferrin concentrations (4 RCTs), and had only a transient effect on the oral microbiome (1 RCT). There were no adverse effects (e.g., aspiration) of OPC. The overall quality of evidence (Grades of Recommendation, Assessment, Development, and Evaluation analysis) was very low. Adequately powered RCTs are needed to confirm the nutritional and immunomodulatory benefits of OPC in preterm infants.
More Related Videos
Related Concept Videos
Suctioning the Oropharyngeal Airway
After assembling the equipment, the nurse should practice hand hygiene and don appropriate PPE according to infection control guidelines to avoid the...
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Directing Effect of Substituents: meta-Directing Groups
Systematic Sampling Method
Systematic sampling is one of the simplest methods...

